›› 2014, Vol. 29 ›› Issue (10): 1049-1052.DOI: 10.3969/j.issn.1673-8640.2014.10.016
• Orginal Article • Previous Articles Next Articles
Received:2013-12-24
Online:2014-10-30
Published:2014-10-22
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2014.10.016
| [1] 李海霞,张春丽,徐国宾,等.健康人群血清半胱氨酸蛋白酶抑制剂C与肌酐分布及其评价慢性肾脏病患者肾小球滤过功能的比较研究[J].中华检验医学杂志,2006,29(11):970-974. [2] 李 丽,杨 帆,毛客自,等. 糖尿病患者肾小球滤过率评估方法的临床应用研究[J]. 检验医学,2012,27(8): 641-646. [3] 马清光,李慧敏,沈 丽,等. 血清半胱氨酸蛋白酶抑制剂C、肌酐评估慢性肾病患者肾小球滤过功能价值的Meta分析[J]. 检验医学, 2012, 27(5): 352-357. [4] 王 敏,王 琦,顾 洁,等. 实验室肾功能相关检测项目在诊断慢性肾病中的特性分析[J]. 检验医学,2012,27(5): 340-344. [5] 郁 淼,张 莉,秦 兵. 血清半胱氨酸蛋白酶抑制剂C在重度子痫前期诊断中的临床意义[J]. 检验医学,2013,28(6): 471-474. [6] 沈 磊,周 锦. Hcy、CysC、RPB在2型糖尿病肾病中的变化分析[J]. 检验医学,2013,28(10): 952-953. [7] 张群妹,郭庆合,鲁广建,等. 尿NGAL和血清Cys C在百草枯中毒患者急性早期肾损伤中的变化及意义[J]. 检验医学,2012,27(11): 940-943. [8] 司马剑华,季叶湘,周晓燕. 血清半胱氨酸蛋白酶抑制剂C测定对糖尿病肾病早期诊断的意义[J]. 检验医学,2011,26(5): 359-360. [9] 欧阳旭,陈汉红,云大壮,等. 血清半胱氨酸蛋白酶抑制剂C对高血压患者早期肾损伤的诊断性能评价[J]. 检验医学,2011,26(5): 317-320. [10] Baxmann AC, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C[J].Clin J Am Soc Nephrol,2008,3(2):348-354. [11] Finney H,Newman DJ, Thakkar H,et al.Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates,and older children[J].Arch Dis Child,2000,82(1):71-75. [12] 戴 悦,吴文清. 两种检测系统测定血清半胱氨酸蛋白酶抑制剂C的偏差评估[J]. 检验医学,2013,28(5): 408-411. [13] 安崇文,李海霞. 7种半胱氨酸蛋白酶抑制剂C检测系统的分析性能评价[J]. 检验医学,2013,28(12): 1106-1111. [14] Randers E,Krue S,Erlandsen EJ,et al. Reference interval for serum cystatin C in children[J].Clin Chem,1999,45(10):1856-1858. [15] Groesbeck D,Kottgen A,Parekh R,et al. Age,gender,and race effects on cystatin C levels in US adolescents[J].Clin J Am Soc Nephrol,2008,3(6):1777-1785. [16] Heiduk M,Päge I,Kliem C,et al.Pediatric reference intervals determined in ambulatory and hospitalized children and juveniles [J].Clin Chim Acta,2009,406(1-2):156-161. [17] Lahti A,Hyltoft Petersen P,Boyd JC,et al.Objective criteria for partitioning Gaussian-distributed reference values into subgroups [J].Clin Chem,2002,48(2):338-352. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
